A brief overview of cell therapy and its product
InSoo Kim, D.D.S., Ph.D.
Division of Oral and Maxillofacial Surgery, Department of Dentistry, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea, Uijeongbu, Korea
MEDICINES IN DEVELOPMENT FOR CELL THERAPY AND GENE THERAPY
Nearly 300 Cell and Gene Therapies in Development for A Broad Range of Diseases
Información al paciente aprobada por el médico (ASCO) Cancer.Net
© 2005-2020 American Society of Clinical Oncology (ASCO).
Reservados los derechos en todo el mundo
A Characterization of Dendritic Cells and Their Role in Immunotherapy in Glioblastoma: From Preclinical Studies to Clinical Trials
Siddhartha Srivastava y, Christina Jackson y , Timothy Kim, John Choi and Michael Lim *
Dendritic Cell-Based Immunotherapy for Solid Tumors
Nam-Chul Jung*´+, Jun-Ho Lee*´+, Kwang-Hoe Chung*, Yi Sub Kwak+ and Dae-Seog Lim*
Autologous Natural Killer Cell Therapy for Human Recurrent Malignant Glioma
EIICHI ISHIKAWA1,2, KOJI TSUBOI1, KAORU SAIJO2, HIDEKI HARADA2, SHINGO TAKANO1, TADAO NOSE1 and TADAO OHNO2
1Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba Science City, Ibaraki 305-8575; 2RIKEN Cell Bank, The Institute of Physical and Chemical Research (RIKEN), 3-1-1 Koyadai, Tsukuba Science City, Ibaraki 305-0074, Japan
NK cells for cancer immunotherapy
Noriko Shimasaki1, Amit Jain1,2 and Dario Campana 1*
Inmunoterapia: Cómo el sistema inmunitario combate el cáncer
How does cancer immunotherapy work?
Células T con CAR: manipulación de células inmunitarias de pacientes para tratar sus cánceres
TIL therapy: 6 things to know
BY CLAYTON BOLDT, PH.D.
Immunotherapy to Treat Cancer
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N Kochenderfer 1, Wyndham H Wilson, John E Janik, Mark E Dudley, Maryalice Stetler-Stevenson, Steven A Feldman, Irina Maric, Mark Raffeld, Debbie-Ann N Nathan, Brock J Lanier, Richard A Morgan, Steven A Rosenberg
CAR T-cell Therapy
The University of Texas MD Anderson Cancer Center